Cargando…
Insufficient S-adenosylhomocysteine hydrolase compromises the beneficial effect of diabetic BMSCs on diabetic cardiomyopathy
BACKGROUND: Autologous stem cell therapy is a promising strategy for cardiovascular diseases including diabetic cardiomyopathy (DCM), but conclusions from clinical trials were compromised. We assumed that diabetes might induce the dysfunction of stem cells and thus limit its therapeutic effect. This...
Autores principales: | Wang, Ying, Zhang, Yuying, Chen, Kegong, Liu, Jie, Wu, Donghong, Cheng, Yao, Wang, Hongjie, Li, Yanbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375418/ https://www.ncbi.nlm.nih.gov/pubmed/35964109 http://dx.doi.org/10.1186/s13287-022-03099-1 |
Ejemplares similares
-
S-adenosylhomocysteine hydrolase over-expression does not alter S-adenosylmethionine or S-adenosylhomocysteine levels in CBS deficient mice
por: Lee, Hyung-Ok, et al.
Publicado: (2018) -
Regulation of homocysteine metabolism by Mycobacterium tuberculosis S-adenosylhomocysteine hydrolase
por: Singhal, Anshika, et al.
Publicado: (2013) -
The biochemical profile and dietary management in S-adenosylhomocysteine hydrolase deficiency
por: Huang, Yue, et al.
Publicado: (2022) -
Abnormal Hypermethylation at Imprinting Control Regions in Patients with S-Adenosylhomocysteine Hydrolase (AHCY) Deficiency
por: Motzek, Antje, et al.
Publicado: (2016) -
Effects of S-Adenosylhomocysteine Hydrolase Downregulation on Wnt Signaling Pathway in SW480 Cells
por: Pavičić, Ivana, et al.
Publicado: (2023)